HALO

+7.5%🟡 Supported direction, extreme size

Halozyme Therapeutics, Inc. · Healthcare

$117.89Vol 2.34M · 1.1× normalMkt cap +$0.94Blive · 2026-10-14 ET

What happened

Move

+7.5%

Price

$117.89

Volume

2.34M

1.1× normal

Market cap

$13.38B

+$0.94B today

Why it moved

Earnings releasemedium confidence

Will Halozyme Therapeutics (HALO) Beat Estimates Again in Its Next Earnings Report? — finnhub-news
TD Cowen Maintains Buy on Halozyme Therapeutics, Raises Price Target to $130 — finnhub-news

Possible catalyst: earnings release, 6.3pp above its sector.

Verdict — was the move justified?

🟡 Supported direction, extreme size

Earnings release supports the direction, but at 4.0σ the reaction is unusually large even for this stock — part of the move may be positioning flow on top of the news.

How unusual is this move

σ score

4.0σ

vs own 20d volatility

Percentile

99th

of 1267 daily moves

Avg daily move

±1.7%

own 5y average

vs sector

+6.3%

beyond sector median

Today’s move is among the largest 1% of HALO’s daily moves over the last 5 years — while the sector moved +1.3% and the market -0.9%.

What happened after similar moves

26 similar up moves in HALO’s 5-year history:

After 5 days

+2.9%

62% higher

After 20 days

+4.3%

69% higher

Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.

Fundamental context

V 44G 50P 95H 75Q 65

Insider activity (90d): net selling $5.71M

Valuation context

P/E (TTM)

30.1

5y median 18.6

P/E percentile

91%

vs own 5y history

FCF yield

0.1%

Trading richer than 91% of its own historical valuation range.

Full fundamental analysis on PreMarketPrice

Pillar scores, financial statements, valuation history, news & more for HALO

→